0001209191-17-029465.txt : 20170502
0001209191-17-029465.hdr.sgml : 20170502
20170502205117
ACCESSION NUMBER: 0001209191-17-029465
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170428
FILED AS OF DATE: 20170502
DATE AS OF CHANGE: 20170502
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Pulse Biosciences, Inc.
CENTRAL INDEX KEY: 0001625101
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 465696597
STATE OF INCORPORATION: NV
FISCAL YEAR END: 1217
BUSINESS ADDRESS:
STREET 1: 849 MITTEN ROAD
STREET 2: SUITE 104
CITY: BURLINGAME
STATE: CA
ZIP: 94010
BUSINESS PHONE: 650-697-3939
MAIL ADDRESS:
STREET 1: 849 MITTEN ROAD
STREET 2: SUITE 104
CITY: BURLINGAME
STATE: CA
ZIP: 94010
FORMER COMPANY:
FORMER CONFORMED NAME: Electroblate, Inc.
DATE OF NAME CHANGE: 20141113
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: DUGGAN ROBERT W
CENTRAL INDEX KEY: 0001055919
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37744
FILM NUMBER: 17806923
MAIL ADDRESS:
STREET 1: 611 SOUTH FORT HARRISON AVE
STREET 2: SUITE 306
CITY: CLEARWATER
STATE: FL
ZIP: 33756
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2017-04-28
0
0001625101
Pulse Biosciences, Inc.
PLSE
0001055919
DUGGAN ROBERT W
611 S. FORT HARRISON AVE., SUITE 306
CLEARWATER
FL
33756
0
0
1
0
Common Stock
2017-04-28
4
P
0
25000
23.85
A
2958579
D
Common Stock
2017-05-01
4
P
0
19348
23.812
A
2977927
D
Common Stock
2017-05-02
4
P
0
5000
23.40
A
2982927
D
Common Stock
2017-04-28
4
P
0
35000
24.00
A
35000
I
See footnote
This is the weighted average purchase price of the shares, which ranged from $23.362 to $23.989 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4.
Shares are held by Genius Accelerated LLC, of which the Reporting Person is the sole member and beneficiary.
Brian Dow, as Attorney-in-Fact for Robert W. Duggan
2017-05-02